BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11649948)

  • 1. Deception and the placebo effect in biomedical research.
    Connelly RJ
    IRB; 1987; 9(4):5-7. PubMed ID: 11649948
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of placebos in randomized clinical trials.
    Levine RJ; Schafer A
    IRB; 1985; 7(2):1-6. PubMed ID: 11649622
    [No Abstract]   [Full Text] [Related]  

  • 3. Sugaring the pill.
    Cohen P
    New Sci; 1996 Jan; 149(2014):26-9. PubMed ID: 11660088
    [No Abstract]   [Full Text] [Related]  

  • 4. Endings of clinical research protocols: distinguishing therapy from research.
    Grinnell F
    IRB; 1990; 12(4):1-3. PubMed ID: 11651260
    [No Abstract]   [Full Text] [Related]  

  • 5. Placebo-controlled trials and the logic of clinical purpose.
    Freedman B
    IRB; 1990; 12(6):1-6. PubMed ID: 11651265
    [No Abstract]   [Full Text] [Related]  

  • 6. The doctor's unproven belief and the subject's informed choice: another commentary.
    Marquis D; Stephens R; Levine RJ
    IRB; 1989; 11(3):8-11. PubMed ID: 11650208
    [No Abstract]   [Full Text] [Related]  

  • 7. The law governing human experimentation in Quebec.
    Kouri RP
    Rev Droit; 1991; 22(1):77-108. PubMed ID: 11659965
    [No Abstract]   [Full Text] [Related]  

  • 8. The ethics of open methods.
    Homan R
    Br J Sociol; 1992 Sep; 43(3):321-32. PubMed ID: 11660181
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspectives of protocol reviewers.
    Moline ML; Aisen MW
    J Calif Alliance Ment Ill; 1994; 5(1):59-60. PubMed ID: 11653327
    [No Abstract]   [Full Text] [Related]  

  • 10. Placebo controls are not good science.
    Weijer C; Appelbaum P
    IRB; 1996; 18(5):8-10. PubMed ID: 11654741
    [No Abstract]   [Full Text] [Related]  

  • 11. The case for per patient payments.
    Lewis JP
    IRB; 1988; 10(5):9. PubMed ID: 11650075
    [No Abstract]   [Full Text] [Related]  

  • 12. Research ethics and clinical trials: fostering collaboration with research participants.
    Phipps E; Fleetwood J; Piraino A
    Account Res; 1999; 6(3):215-26. PubMed ID: 11658125
    [No Abstract]   [Full Text] [Related]  

  • 13. Issues related to the protection of human research participants.
    Harrison L
    J Neurosurg Nurs; 1993 Jun; 25(3):187-93. PubMed ID: 11660053
    [No Abstract]   [Full Text] [Related]  

  • 14. Ethics of drug experimentation.
    Sgreccia E
    Dolentium Hominum; 1987; 4(2nd Yr. 1):60-75. PubMed ID: 11653200
    [No Abstract]   [Full Text] [Related]  

  • 15. Research report: Norplant, the five year needle -- an investigation of the Norplant trial in Bangladesh from the user's perspective.
    UBINIG
    Issues Reprod Genet Eng; 1990; 3(3):211-28. PubMed ID: 11650964
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-free research in schizophrenia: an overview of the controversy.
    Appelbaum PS
    IRB; 1996; 18(1):1-5. PubMed ID: 11660192
    [No Abstract]   [Full Text] [Related]  

  • 17. The changing clinical trials scene: the role of the IRB.
    Mitchell SC; Steingrub J
    IRB; 1988; 10(4):1-5. PubMed ID: 11650078
    [No Abstract]   [Full Text] [Related]  

  • 18. Protocol review within the context of a research program.
    Miller FG; Rosenstein DL
    IRB; 1998; 20(4):7-10. PubMed ID: 11657088
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of placebo and deception.
    Saber FA; Reece RD
    IRB; 1979; 1(4):4-6. PubMed ID: 11665068
    [No Abstract]   [Full Text] [Related]  

  • 20. "The price of Norplant is TK.2000! You cannot remove it." -- Clients are refused removal in Norplant trial in Bangladesh.
    UBINIG
    Issues Reprod Genet Eng; 1991; 4(1):45-6. PubMed ID: 11651370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.